GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
Latest Information Update: 23 Jul 2021
At a glance
- Drugs Semaglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 09 Jul 2021 Phase of the trial has been changed from 2 to 1 and masking changed from open label to double-blind.
- 09 Jul 2021 Planned primary completion date changed from 30 Jun 2025 to 1 Jan 2025.
- 08 Mar 2021 New trial record